InterCure Ltd. (dba Canndoc) (NASDAQ: INCR | TASE: INCR) is the leading, profitable, and fastest-growing cannabis company outside of North America. Through its wholly owned subsidiary Canndoc Ltd., InterCure is Israel’s largest licensed cannabis producer and a pioneer in delivering GMP-certified, pharmaceutical-grade medical cannabis products.

​​

Building on its strong foundation of scientific excellence and decades of expertise, InterCure has created a vertically integrated “seed-to-sale” ecosystem that spans cultivation, manufacturing, and nationwide distribution. The company owns and operates Givol - Israel’s premier medical cannabis pharmacy chain - as well as Leon Pharm, both serving tens of thousands of patients with access to high-quality pharmaceutical-grade medical cannabis products, expert pharmaceutical guidance, and personalized patient care.